North America Medical Foods for Inborn Errors of Metabolism Market

North America Medical Foods for Inborn Errors of Metabolism Market


North America medical foods for inborn errors of metabolism market is expected to reach USD 3,941.16 million by 2031 from USD 1,195.86 million in 2022, growing at a CAGR of 14.4% during the forecast period of 2023 to 2031.
Market Segmentation:
North America Medical Foods for Inborn Errors of Metabolism Market, By Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, and Others), Diseases (Phenylketonuria (PKU), Ryrosinemia Types I And II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Academia, Disorders Of Leucine Metabolism, and Others), Age Group (Infants, Weaning, Adolescent, and Adults), Forms (Powder, Liquid, Tablets , Gels, and Others), Packaging (Can, Jar, Packets, Bottle, and Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Drugs Store, and Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2031

Overview of North America Medical Foods for Inborn Errors of Metabolism Market Dynamics:

Drivers
• Rising incidence of inborn errors of metabolism
• Rising preference of dietary supplements over enzyme replacement therapy
• Increase in the number of new born screening procedures
• Increasing spending on medical food products
Restraints
• High cost of medical food
• Stringent regulations for medical foods
Opportunities
• Government initiatives and programs for creating awareness about IEM
• Increasing collaboration and partnerships in the market
• Expansion of medical foods in emerging market
Challenges
• Poor accessibility of medical foods
• Alternative treatment approaches for inborn errors of metabolism




Market Players:

The key market players operating in the North America medical foods for inborn errors of metabolism market are listed below:
• Abbott
• Nestlé Health Science
• Meiji Holdings Co., Ltd
• Baxter
• Pristine Organics Pvt Ltd.
• Promin
• Solace Nutrition
• EBM Medical, Galen Limited
• Hexagon Nutrition Ltd.
• Kate Farms
• Ajinomoto Cambrooke, Inc.
• Mead Johnson & Company, LLC.
• Nutricia
• B. Braun SE
• Orpharma Pty Ltd.
• Piam Farmaceutici S.P.A.
• PKU-Mdmil.com
• Primus Pharmaceuticals, inc.
• Biovencer Healthcare Pvt Ltd

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 DBMR Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 DBMR Market Position Grid
2.8 Secondary Sources
2.9 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Epidemiology
4.1.1 Prevalence Of Inborn Errors Of Metabolism
4.1.2 New-born Screening Programs
4.1.3 Genetic Heterogeneity
4.1.4 Impact On Health
4.1.5 Clinical Impac
4.1.6 Treatment And Management
4.2 Pestle Analysis
4.2.1 Political Factors
4.2.2 Economic Factors
4.2.3 Social Factors
4.2.4 Technological Factors
4.2.5 Environmental Factors
4.2.6 Legal Factors
4.3 Porter’s Five Forces
4.3.1 Threat Of New Entrants
4.3.2 Threat Of Substitutes
4.3.3 Bargaining Power Of Buyers
4.3.4 Bargaining Power Of Suppliers
4.3.5 Competitive Rivalry
4.4 Industry Insights
4.4.1 Demographic Trends
4.4.2 Key Pricing Strategies
4.4.3 Key Patient Enrollment Strategies
4.5 Patent Analysis
4.6 Pipeline Analysis
4.6.1 Research And Development
4.6.2 Clinical Trials
4.6.3 Regulatory Approval
4.6.4 Manufacturing And Production
4.6.5 Commercialization And Market Access
4.6.6 Distribution And Supply Chain Management
4.6.7 Post-market Surveillance And Monitoring
4.7 Regulation Coverage
5 Market Overview
5.1 Drivers
5.1.1 Rising Incidences Of Inborn Errors Of Metabolism (Iem)
5.1.2 Rising Preference For Dietary Supplements Over Enzyme Replacement Therapy (Ert)
5.1.3 Increase In The Number Of New-born Screening Procedures
5.1.4 Increasing Spending On Medical Food Products
5.2 Restraints
5.2.1 High Cost Of Medical Foods
5.2.2 Stringent Regulations For Medical Foods
5.3 Opportunities
5.3.1 Government Initiatives And Programs For Creating Awareness About Inborn Errors Of Metabolism
5.3.2 Increasing Collaborations And Partnerships In The Market
5.3.3 Expansion Of Medical Foods In Emerging Markets
5.4 Challenges
5.4.1 Poor Accessibility Of Medical Foods
5.4.2 Alternative Treatment Approaches For Inborn Errors Of Metabolism
6 North America Medical Foods For Inborn Errors Of Metabolism Market, By Products
6.1 Overview
6.2 Amino Acid
6.2.1 Amino Acid, By Products
6.2.1.1 Amino Acid Mixtures, By Products
6.2.1.2 Phenylade, By Products
6.2.1.1 Single Amino Acids, By Products
6.3 Low Protein Food
6.3.1 Low Protein Food, By Products
6.4 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron
6.4.1 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron, By Flavors
6.4.2 Glytactin With Gmp Amino Acid-modified Infant Formula With Iron, By Usages
6.5 Low-calcium/Vitamin D-free Infant Formula With Iron
6.5.1 Low-calcium/Vitamin D-free Infant Formula With Iron, By Products
6.6 Others
7 North America Medical Foods For Inborn Errors Of Metabolism Market, By Diseases
7.1 Overview
7.2 Phenylketonuria (Pku)
7.2.1 Phenylketonuria (Pku), By Diseases
7.3 Tyrosinemia Types I And Ii
7.4 Maple Syrup Urine Disease (Msud)
7.4.1 Maple Syrup Urine Disease (Msud), By Diseases
7.5 Homocystinuria
7.5.1 Glutaric Acidemia Type I
7.6 Urea Cycle Disorders
7.6.1 Urea Cycle Disorders, By Diseases
7.7 Methylmalonic Acidemia
7.7.1 Isovaleric Acidemia
7.8 Organic Acidurias
7.9 Renal Disease
7.10 Propionic Acidemia
7.11 Disorders Of Leucine Metabolism
7.12 Others
8 North America Medical Foods For Inborn Errors Of Metabolism Market, By Age Group
8.1 Overview
8.2 Infants
8.3 Weaning
8.4 Adolescent
8.5 Adults
9 North America Medical Foods For Inborn Errors Of Metabolism Market, By Forms
9.1 Overview
9.2 Powder
9.3 Liquid
9.4 Tablets
9.5 Gels
9.6 Others
10 North America Medical Foods For Inborn Errors Of Metabolism Market, By Packaging
10.1 Overview
10.2 Can
10.3 Packets
10.4 Bottle
10.5 Jar
10.6 Others
11 North America Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel
11.1 Overview
11.2 Hospital Pharmacy
11.3 Retail Pharmacy
11.4 Drug Stores
11.5 Online Pharmacy
11.6 Others
12 North America Medical Foods For Inborn Errors Of Metabolism Market, By Region
12.1 North America
12.1.1 U S
12.1.2 Canada
12.1.3 Mexico
13 North America Medical Foods For Inborn Errors Of Metabolism Market: Company Landscape
13.1 Company Share Analysis: North America
14 Swot Analysis
15 Company Profile
15.1 Abbott
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Development
15.2 Nestlé Health Science (A Subsidiary Of Nestlé)
15.2.1 Company Snapshot
15.2.2 Company Share Analysis
15.2.3 Product Portfolio
15.2.4 Recent Developments
15.3 Meiji Holdings Co., Ltd.
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Baxter
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Development
15.5 Pristine Organics Pvt Ltd.
15.5.1 Company Snapshot
15.5.2 Company Share Analysis
15.5.3 Product Portfolio
15.5.4 Recent Development
15.6 Ajinomoto Cambrooke, Inc. (A Subsidiary Of Ajinomoto Co., Inc.)
15.6.1 Company Snapshot
15.6.2 Product Portfolio
15.6.3 Recent Developments
15.7 B.Braun Se
15.7.1 Company Snapshot
15.7.2 Product Portfolio
15.7.3 Recent Development
15.8 Biovencer Healthcare Pvt Ltd
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Ebm Medical
15.9.1 Company Snapshot
15.9.2 Product Portfolio
15.9.3 Recent Development
15.10 Galen Limited
15.10.1 Company Snapshot
15.10.2 Product Portfolio
15.10.3 Recent Developments
15.11 Hexagon Nutrition Ltd.
15.11.1 Company Snapshot
15.11.2 Product Portfolio
15.11.3 Recent Development
15.12 Kate Farms
15.12.1 Company Snapshot
15.12.2 Product Portfolio
15.12.3 Recent Developments
15.13 Mead Johnson & Company, Llc. (A Subsidiary Of Reckitt Benckiser Group Plc.)
15.13.1 Company Snapshot
15.13.2 Product Portfolio
15.13.3 Recent Development
15.14 Nutricia (A Subsidiary Of Danone)
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Orpharma Pty Ltd.
15.15.1 Company Snapshot
15.15.2 Product Portfolio
15.15.3 Recent Development
15.16 Piam Farmaceutici S.P.A
15.16.1 Company Snapshot
15.16.2 Product Portfolio
15.16.3 Recent Development
15.17 Pku-mdmil
15.17.1 Company Snapshot
15.17.2 Product Portfolio
15.17.3 Recent Development
15.18 Primus Pharmaceuticals, Inc.
15.18.1 Company Snapshot
15.18.2 Product Portfolio
15.18.3 Recent Development
15.19 Promin
15.19.1 Company Snapshot
15.19.2 Product Portfolio
15.19.3 Recent Development
15.20 Solace Nutrition
15.20.1 Company Snapshot
15.20.2 Product Portfolio
15.20.3 Recent Development
16 Questionnaire
17 Related Reports
Table 1 Costs Of Medical Foods Used In Inborn Errors Of Metabolism (Iems)
Table 2 Patent Analysis
Table 3 Regulatory Coverage
Table 4 Costs Of Medical Foods
Table 5 North America Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 6 North America Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 7 North America Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 8 North America Amino Acids Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 9 North America Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 10 North America Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 11 North America Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 12 North America Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 13 North America Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 14 North America Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 15 North America Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 16 North America Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 17 North America Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 18 North America Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 19 North America Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 20 North America Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 21 North America Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 22 North America Tyrosinemia Types I And Ii In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 23 North America Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 24 North America Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 25 North America Homocystinuria In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 26 North America Glutaric Acidemia Type I In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 27 North America Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 28 North America Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 29 North America Methylmalonic Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 30 North America Isovaleric Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 31 North America Organic Acidurias In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 32 North America Renal Disease In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 33 North America Propionic Acidemia In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 34 North America Disorders Of Leucine Metabolism In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 35 North America Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 36 North America Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 37 North America Infants In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 38 North America Weaning In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 39 North America Adolescent In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 40 North America Adults In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 41 North America Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 42 North America Powder In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 43 North America Liquid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 44 North America Tablets In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 45 North America Gels In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 46 North America Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 47 North America Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 48 North America Can In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 49 North America Liquid In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 50 North America Bottle In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 51 North America Jar In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 52 North America Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 53 North America Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 54 North America Hospital Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 55 North America Retail Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 56 North America Drug Stores In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 57 North America Online Pharmacy In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 58 North America Others In Medical Foods For Inborn Errors Of Metabolism Market, By Region, 2018-2031 (Usd Thousand)
Table 59 North America Medical Foods For Inborn Errors Of Metabolism Market, By Country, 2018-2031 (Usd Thousand)
Table 60 North America Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 61 North America Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 62 North America Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 63 North America Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 64 North America Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 65 North America Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 66 North America Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 67 North America Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 68 North America Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 69 North America Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 70 North America Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 71 North America Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 72 North America Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 73 North America Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 74 North America Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 75 North America Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 76 North America Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 77 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 78 U.S. Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 79 U.S. Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 80 U.S. Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 81 U.S. Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 82 U.S. Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 83 U.S. Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 84 U.S. Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 85 U.S. Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 86 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 87 U.S. Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 88 U.S. Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 89 U.S. Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 90 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 91 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 92 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 93 U.S. Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 94 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 95 Canada Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 96 Canada Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 97 Canada Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 98 Canada Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 99 Canada Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 100 Canada Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 101 Canada Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 102 Canada Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 103 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 104 Canada Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 105 Canada Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 106 Canada Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 107 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 108 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 109 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 110 Canada Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Table 111 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 112 Mexico Amino Acid In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 113 Mexico Amino Acid Mixtures In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 114 Mexico Phenylade In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 115 Mexico Single Amino Acids In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 116 Mexico Low Protein Food In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 117 Mexico Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Flavors, 2018-2031 (Usd Thousand)
Table 118 Mexico Glytactin With Gmp Amino Acid-modified Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Usages, 2018-2031 (Usd Thousand)
Table 119 Mexico Low-calcium/Vitamin D-free Infant Formula With Iron In Medical Foods For Inborn Errors Of Metabolism Market, By Products, 2018-2031 (Usd Thousand)
Table 120 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 121 Mexico Phenylketonuria (Pku) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 122 Mexico Maple Syrup Urine Disease (Msud) In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 123 Mexico Urea Cycle Disorders In Medical Foods For Inborn Errors Of Metabolism Market, By Diseases, 2018-2031 (Usd Thousand)
Table 124 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Age Group, 2018-2031 (Usd Thousand)
Table 125 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Forms, 2018-2031 (Usd Thousand)
Table 126 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Packaging, 2018-2031 (Usd Thousand)
Table 127 Mexico Medical Foods For Inborn Errors Of Metabolism Market, By Distribution Channel, 2018-2031 (Usd Thousand)
Figure 1 North America Medical Foods For Inborn Errors Of Metabolism Market: Segmentation
Figure 2 North America Medical Foods For Inborn Errors Of Metabolism Market: Data Triangulation
Figure 3 North America Medical Foods For Inborn Errors Of Metabolism Market: Droc Analysis
Figure 4 North America Medical Foods For Inborn Errors Of Metabolism Market: North America Vs Regional Market Analysis
Figure 5 North America Medical Foods For Inborn Errors Of Metabolism Market: Company Research Analysis
Figure 6 North America Medical Foods For Inborn Errors Of Metabolism Market: Interview Demographics
Figure 7 North America Medical Foods For Inborn Errors Of Metabolism Market: DBMR Market Position Grid
Figure 8 North America Medical Foods For Inborn Errors Of Metabolism Market: Segmentation
Figure 9 A Rise In The Incidence Of Inborn Errors Of Metabolism And An Increase In The Number Of The Newborn Screening Procedures Are Expected To Drive The North America Medical Foods For Inborn Errors Of Metabolism Market Growth In The Forecast Period Of 2023 To 2031
Figure 10 The Amino Acid Segment Is Expected To Account For The Largest Share Of The North America Medical Foods For Inborn Errors Of Metabolism Market In 2023 And 2031
Figure 11 Epidemiology
Figure 12 Porter’s Five Forces
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of North America Medical Foods For Inborn Errors Of Metabolism Market
Figure 14 North America Medical Foods For Inborn Errors Of Metabolism Market: By Products, 2022
Figure 15 North America Medical Foods For Inborn Errors Of Metabolism Market: By Diseases, 2022
Figure 16 North America Medical Foods For Inborn Errors Of Metabolism Market: By Age Group, 2022
Figure 17 North America Medical Foods For Inborn Errors Of Metabolism Market: By Forms, 2022
Figure 18 North America Medical Foods For Inborn Errors Of Metabolism Market: By Packaging, 2022
Figure 19 North America Medical Foods For Inborn Errors Of Metabolism Market: By Distribution Channel, 2022
Figure 20 North America Medical Foods For Inborn Errors Of Metabolism Market: Snapshot (2022)
Figure 21 North America Medical Foods For Inborn Errors Of Metabolism Market: Company Share 2023 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings